Hajar Motamed

Hajar Motamed

Auto-generated profile, based on publicly available information

Hajar Motamed

Department of Pathology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Indian Journal of Medical and Paediatric Oncology
Verified
Journal Article
Open access
PDF file
SMSeyed-Hamid Madani
Seyed-Hamid Madani
MPMehrdad Payandeh
Mehrdad Payandeh
Masoud SadeghiMasoud Sadeghi
Masoud Sadeghi
HMHajar Motamed
Hajar Motamed
ESEdris Sadeghi
Edris Sadeghi
Context: Despite the fact that breast cancer (BC) is a major health issue, very few studies describe its characteristics in the Middle East. Aim: The aim of this study was to evaluate the use and value of Ki-67 as a prognostic marker in BC and associations between Ki-67, clinical, and histopathological parameters were evaluated. Subjects and Methods: In a retrospective study, 260 BC women and invasive ductal carcinoma were included to our study in Kermanshah city, Iran. Age, tumor size, lymph node involvement, histological grade, nuclear grade, and vascular invasion were other factors that determined in a lot of patients. Results: The mean age at diagnosis was 47.6 years (range, 24-84 years) with 100% female. Of 243 patients that tumor size was determined for them, 207 patients (85.2%) had tumor size ≥ 2 cm, and 36 patients (14.8%) had size <2 cm and also of 237 patients, 47 patients (19.8%), 140 (59.1%), and 50 (21.1%) had histological grades I, II, and III, respectively. There is significant correlation between Ki-67 with nuclear grade, human epidermal growth factor receptor 2 (HER2), and p53 (P < 0.05). Based on this result, more patients with Ki-67 ≥ 20% have higher nuclear grade, p53-positive, and HER2-positive. There was correlation between Ki-67 with type of tumor (P = 0.009). Conclusions: The higher Ki-67 has a direct significant correlation with higher nuclear grade, p53-positive, and HER2-positive. Furthermore, triple negative patients have higher Ki-67 compared to other subtypes.

1 June 2020
Verified
Closed access
PDF file
MVMazyar Vakiliamini
Mazyar Vakiliamini
HBHoma Babaei
Homa Babaei
MMMaryam Mohammadi
Maryam Mohammadi
RHReza Habibi
Reza Habibi
HMHajar Motamed
Hajar Motamed

1 January 2025 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
HMHajar Motamed
Hajar Motamed
SSShadi Siami
Shadi Siami
ZAZahra Abdan
Zahra Abdan
FMFaruq Mozafari
Faruq Mozafari
SKSedigheh Khazaei
Sedigheh Khazaei
FHFatemeh Heydarpour
Fatemeh Heydarpour
Motamed H, et al. Clin Exp Vaccine Res. 2025 May;14:e24. https://doi.org/10.7774/cevr.2025.14.e24

25 February 2026
Verified
Journal Article
Open access
PDF file
MVMazyar Vakiliamini
Mazyar Vakiliamini
RHReza Habibi
Reza Habibi
SZSamira Zarei
Samira Zarei
RLRoya Chegene Lorestani
Roya Chegene Lorestani
FRFatemeh Rezaeeniya
Fatemeh Rezaeeniya
HMHajar Motamed
Hajar Motamed
This study aimed to evaluate the concurrent effects of consuming Rhamnosus probiotics and oral antifungal Nystatin on inhibiting Candida (C.) albicans colonization in infants weighing <2,500 grams. This study was a randomized controlled clinical trial conducted on 104 infants born weighing <2,500 grams at Mohammad Kermanshahi Hospital in Kermanshah in 2021–22. The infants were randomly allocated into intervention (n=52) and control (n=52) groups. The control group received a placebo, 10 drops orally four times daily. In contrast, the intervention group received oral Nystatin 100,000 units 10 drops three times a day, combined with Rhamnosus Lactobacillus oral drops once daily for 7 to 10 days. The results showed a lower frequency of positive C. albicans cultures in stool samples on the 7th day of age in the intervention group. Moreover, several variables such as the onset of nutrition, time to reach 100 ml/kg of milk intake per day, number of nil per os (NPO; “nothing through the mouth”) episodes, total NPO time during hospitalization, episodes of intolerance until discharge, and duration of hospitalization were significantly lower in the intervention group compared to the control. The concurrent use of Rhamnosus probiotics and oral Nystatin can lead to a reduction of positive C. albicans stool culture results, average time for certain variables such as the onset of nutrition, time to reach 100 ml/kg of milk intake per day, NPO days, total NPO time during hospitalization, episodes of intolerance until discharge, and duration of hospitalization in infants weighing <2,500 grams. Hence, their simultaneous administration is recommended for these neonates.